Current status of dengue fever epidemics and vaccine development
February 2026
Dengue fever, an acute mosquito-borne infectious disease caused by dengue virus (DENV), is primarily endemic in tropical and subtropical regions. In recent years, the global incidence of dengue has...
The role of T cells in influenza infection and vaccination
February 2026
Influenza virus infections cause significant illness or death every year, becoming a serious health risk. Currently, influenza vaccines mainly induce responses to antibodies against specific strains,...
Antiviral agents for dengue virus
December 2025
Dengue virus (DENV) is a mosquito-borne pathogen responsible for a spectrum of illnesses, including dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. Nearly half of the global population...
Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus
April 2026
Vaccination stands as the single most effective and cost-efficient public health intervention in human history, serving as a cornerstone of modern medicine that profoundly transforms global health outcomes....
Crimean-Congo hemorrhagic fever: An emerging threat in Europe
Available online 15 December 2025
Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-Congo hemorrhagic fever virus (CCHFV), is endemic in Africa, Asia, and Europe. However, CCHF epidemiology and epizootiology have been poorly...
Current antiviral therapies and promising drug candidates against respiratory syncytial virus infection
April 2025
Respiratory syncytial virus (RSV) is one of the most common viruses leading to lower respiratory tract infections (LRTIs) in children and elderly individuals worldwide. Although significant progress...
Revisiting influenza A virus life cycle from a perspective of genome balance
February 2023
Influenza A virus (IAV) genome comprises eight negative-sense RNA segments, of which the replication is well orchestrated and the delicate balance of multiple segments are dynamically regulated throughout...
Identification of a novel HIV-1 circulating recombinant form (CRF161_0107) from CRF01_AE-C5 lineage among men who have sex with men in southwestern China
April 2026
•Identification of a novel HIV-1 circulating recombinant form (CRF161_0107) in Chinese men who have sex with men.•CRF161_0107 emerged around 2016, exhibiting unique CRF01_AE-C5 and CRF07_BC-N parental...
Breaking barriers and beyond: Mechanisms and pathological implications of Zika virus traversal across blood-tissue interfaces
April 2026
Blood-tissue barriers are specialized interfaces that safeguard organ homeostasis by restricting pathogen dissemination. Zika virus (ZIKV), an emerging flavivirus of global concern, exhibits an exceptional...
Emergence of a novel H4N6 avian influenza virus with mammalian adaptation isolated from migratory birds in Zhejiang Province, China, 2024
April 2026
•The H4N6/G030 strain, a novel H4N6 avian influenza virus (AIV), was isolated from a red-necked stint.•The H4N6/G030 is a novel cross-species reassortant derived from wild bird and poultry AIV lineages.•The...
Metatranscriptomics uncovers host immune and microbiome signatures specific to and shared between human metapneumovirus and respiratory syncytial virus infections in children
April 2026
Human metapneumovirus (hMPV) is a prevalent respiratory virus in children with acute lower respiratory tract infections that is highly homologous with respiratory syncytial virus (RSV), the primary...
Genomic-epidemiological analysis of 15 million SARS-CoV-2 genomes reveals accelerated fitness gain of JN.1 lineage
April 2026
The evolution of SARS-CoV-2 has been driven by successive globally circulating waves, including the Alpha and Delta lineages, early Omicron (BA.1–BA.5), XBB, and the recently dominant JN.1 lineages....
Generation of G9 genotype porcine rotavirus using reverse genetics system and its application for antiviral screen and vaccine development
April 2026
Group A rotaviruses (RVs) continue to be one of the most important pathogens causing severe acute gastroenteritis in infants and young animals worldwide. Recently, the prevalence of porcine RV (PoRV)...
ZNF219 inhibits porcine epidemic diarrhea virus by degrading viral S2 protein
April 2026
Since its discovery, porcine epidemic diarrhea virus (PEDV) has significantly affected the agricultural economy worldwide. The available commercialized coronavirus vaccines cannot adequately control...
Feline calicivirus VP1-based mRNA vaccine protects cats against FCV challenge
April 2026
•An FCV-VP1 mRNA-LNP vaccine was constructed, utilizing a safe, flexible non-viral platform.•The vaccine elicits effective, durable neutralizing antibodies, protecting cats from FCV challenge.•This...
A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses
April 2026
Influenza A viruses (IAVs) are significant respiratory pathogens characterized by high mutation rates and frequent genetic reassortments, underscoring the need for vaccines that can induce robust and...
Hepatitis B virus promotes hepatocellular carcinoma progression by disrupting NSUN2/YBX1-mediated m5C modification of PTEN mRNA
Available online 12 March 2026
Hepatitis B virus (HBV) has been implicated in hepatocellular carcinoma (HCC) progression, partly through regulation of the tumor suppressor phosphatase and tensin homolog (PTEN). Although transcriptional...
Metatranscriptomics profiling reveals rodent- and shrew-borne viral diversity and evolutionary relationships in Guangzhou, China
February 2026
Emerging zoonotic infectious diseases, predominantly caused by viruses, pose increasing public health threats globally. Rodents and shrews are natural hosts for a variety of zoonotic viruses. Guangzhou...
Genomic evidence of HMPV resurgence in Beijing: Clade B2 triggers the 2024 winter epidemic peak
February 2026
With an unexpected increase of human metapneumovirus (hMPV) cases in northern China since late 2024, concerns arose whether novel hMPV variants triggered this epidemic. Utilizing the Beijing Respiratory...
GlycoRNAs: Biological functions and novel antiviral targets
February 2026
•GlycoRNAs on host cell surfaces serve as adhesive molecules for viral internalization.•GlycoRNAs may interact with immunomodulatory receptors and facilitate immune recognition and responses.•Targeting...
Nanobody targeting glycan cap confers broad orthoebolavirus neutralization
April 2026
The Zaire Ebola virus (EBOV) and Bundibugyo virus (BDBV) cause severe hemorrhagic fever with high mortality, highlighting the urgent need for broad-spectrum antiviral therapies. Neutralizing nanobodies,...
Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers
February 2025
Rotavirus infections cause severe gastroenteritis and dehydration in young children and animals worldwide, leading to high rates of morbidity and mortality, predominantly in low- and middle-income countries....
Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections
February 2026
Despite widespread use of multiple PCR, a substantial proportion of pediatric acute respiratory tract infections (ARTIs) lack identifiable pathogens and are classified as unknown etiology. The microbial...
Evidence of human exposure to tick-borne viruses based on viromes of ticks and presence of specific antibodies among patients in Hainan Island, southern China
February 2026
Hainan Island, located in the South China Sea, is known as an area with diseases related to Rickettsia spp. or spirochete infection; however, the potential threat there from infection with tick-borne...
STING1 negatively regulates translation and replication of foot-and-mouth disease virus independently of interferon and is antagonized by the viral proteins 3C and 2B
April 2026
Foot-and-mouth disease virus (FMDV), a highly contagious picornavirus, employs multifaceted strategies to evade host innate immunity, with viral proteins 3C protease (3Cpro) and 2B serving as key immune...
